Holitilin (Choline alfoscerate) 400 mg

Always fresh Holitilin (Choline alfoscerate) 400 mg

English product name
Cholitilin

Release Form
caps. 400 mg: 10, 14 20, 28, 30, 40, 42 or 56 pcs.

Description
Capsules 1 cap.
choline alfoscerate 400 mg

ATC codes
N07AX02 Choline alfoscerate

Clinical-pharmacological groups / Group affiliation
Nootropic drug. Central Action Cholinomimetic

Active substance
choline alfoscerate

Pharmaco-therapeutic group Holitilin

Nootropic agent 

Pharmacological effect Holitilin

Holinomimetic. It is a precursor to acetylcholine. It mainly affects cholinergic receptors in the CNS. Glycerophosphate, which is formed by cleavage of the choline alfoscerate, is a precursor to the phospholipids (phosphatidylcholine) of the neuron membrane. It facilitates the transmission of nerve impulses in cholinergic neurons, improves the plasticity of neuronal membranes and the function of receptors.

Testimony Holitilin

Acute period of head trauma with mainly stem level of lesions, chronic cerebrovascular insufficiency (discirculatory encephalopathy); dementia syndrome of various genesis, including Alzheimer's disease; ischemic stroke (early and late recovery period); Gettington's chorea; senile pseudomelancholy.

Method of use, course and dosage

Inside: 400 mg three times a day, treatment course three - six months. one gr of day.

• Nosology (ICD codes)
• F00
• Dementia in Alzheimer's
• F01
• Vascular dementia
• F03
• Dementia unspecified
• F07
• Personality and behavioural disorders caused by disease, damage or brain dysfunction
• G10
• Guentington Chorea
• G93.4
• Encephalopathy unrefined
• I63
• Brain infarction
• S06
• Intracranial injury